Sex related differences in muscle health and metabolism in chronic obstructive pulmonary disease

Clin Nutr. 2023 Sep;42(9):1737-1746. doi: 10.1016/j.clnu.2023.06.031. Epub 2023 Jul 26.

Abstract

Background & aims: Sex differences in muscle function and mass, dyspnea, and clinical outcomes have been observed in patients with Chronic Obstructive Pulmonary Disease (COPD) despite a similar level of airflow obstruction. Protein and amino acid metabolism is altered in COPD, however, it remains unclear whether a difference in metabolic signature exists between males and females with COPD that may explain the observed differences in muscle health and clinical outcomes.

Methods: In 234 moderate to severe COPD patients (males/females: 113/121) and 182 healthy controls (males/females: 77/105), we assessed, besides presence of comorbidities and clinical features, muscle function by handgrip and leg dynamometry, and body composition by dual-energy x-ray absorptiometry. In the postabsorptive state, a mixture of 18 stable isotopes of amino acids was administered by pulse and arterialized blood was sampled for 2 h. Amino acid concentrations and enrichments were analyzed by LC-MS/MS to calculate whole body (net) protein breakdown (WBnetPB) and whole body production (WBP) rates (μmol/hour) of the amino acids playing a known role in muscle health. Statistics was done by ANCOVA to examine the effects of sex, COPD, and sex-by-COPD interaction with as covariates age and lean mass. Significance was set as p < 0.05.

Results: Lung function was comparable between males and females with COPD. Being a female and presence of COPD were independently associated with lower appendicular lean mass, muscle strength, and WBnetPB (p < 0.05). Being a male was associated with higher visceral adipose tissue, C-reactive protein (CRP) (p < 0.05), and higher prevalence of heart failure and obstructive sleep apnea. Sex-by-COPD interactions were found indicating lower fat mass (p = 0.0005) and WBPs of phenylalanine (measure of whole body protein turnover) and essential amino acids (p < 0.05), particularly in COPD females. Higher visceral adipose tissue (p = 0.025), CRP (p < 0.0001), and WBP of tau-methylhistidine (p = 0.010) (reflecting enhanced myofibrillar protein breakdown) were observed in COPD males.

Conclusions: Presence of sex specific changes in protein and amino acid metabolism and cardiometabolic health in COPD need to be considered when designing treatment regimens to restore muscle health in males and females with COPD.

Clinical trial registry: www.

Clinicaltrials: gov, NCT01787682, NCT01624792, NCT02157844, NCT02065141, NCT02770092, NCT02780219, NCT03327181, NCT03796455, NCT01173354, NCT01154400.

Keywords: Body composition; COPD; Muscle function; Phenotype; Protein and amino acid kinetics; Stable isotope tracers.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acids
  • Chromatography, Liquid
  • Female
  • Hand Strength*
  • Humans
  • Male
  • Muscle, Skeletal
  • Proteins / metabolism
  • Pulmonary Disease, Chronic Obstructive*
  • Sex Characteristics
  • Tandem Mass Spectrometry

Substances

  • Amino Acids
  • Proteins

Associated data

  • ClinicalTrials.gov/NCT03796455
  • ClinicalTrials.gov/NCT03327181
  • ClinicalTrials.gov/NCT01154400
  • ClinicalTrials.gov/NCT01173354
  • ClinicalTrials.gov/NCT01787682
  • ClinicalTrials.gov/NCT01624792
  • ClinicalTrials.gov/NCT02157844
  • ClinicalTrials.gov/NCT02065141
  • ClinicalTrials.gov/NCT02770092
  • ClinicalTrials.gov/NCT02780219